Brachydactylous dwarfism, Mseleni type

Brachydactylous dwarfism, Mseleni type (also known as Mseleni joint disease) is a rare skeletal disorder originally described in the Mseleni region of KwaZulu-Natal, South Africa. It is characterized by a distinctive form of short stature (dwarfism) combined with brachydactyly (shortened fingers and toes) and a severe, progressive arthropathy (joint disease). The condition primarily affects the musculoskeletal system, with prominent involvement of the hip joints, knees, ankles, and hands. Affected individuals typically develop progressive joint pain, stiffness, and deformity, often leading to significant disability. Radiographic findings include flattened femoral heads (similar to those seen in spondyloepiphyseal dysplasia), irregular joint surfaces, and shortened metacarpals and phalanges. The hips are often the most severely affected joints, and many patients develop a waddling gait due to bilateral hip involvement. The condition appears to be endemic to the Mseleni area, and its exact etiology remains debated, with both genetic and environmental factors (such as nutritional deficiencies or trace element imbalances) having been proposed as contributing causes. There is currently no curative treatment for Mseleni joint disease. Management is supportive and symptomatic, focusing on pain relief with analgesics and anti-inflammatory medications, physical therapy to maintain joint mobility, and in severe cases, surgical interventions such as total hip replacement. The condition can lead to significant functional impairment, particularly in advanced stages when joint destruction is extensive.

Common questions about Brachydactylous dwarfism, Mseleni type